Lysosomal Storage Disorder

Gene: GM2A

Green List (high evidence)

GM2A (GM2 ganglioside activator, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000196743
EnsemblGeneIds (GRCh37): ENSG00000196743
OMIM: 613109, ClinGen, DECIPHER
GM2A is in 14 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Well established gene-disease association.
Sources: Expert list
Created: 24 Jul 2020, 11:14 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
GM2-gangliosidosis, AB variant, MIM# 272750

History Filter Activity

24 Jul 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: gm2a has been classified as Green List (High Evidence).

24 Jul 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: gm2a has been classified as Green List (High Evidence).

24 Jul 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: GM2A was added gene: GM2A was added to Lysosomal Storage Disorder. Sources: Expert list Mode of inheritance for gene: GM2A was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: GM2A were set to GM2-gangliosidosis, AB variant, MIM# 272750 Review for gene: GM2A was set to GREEN